US EditionNovo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill
Summary by Investor's Business Daily
3 Articles
3 Articles
All
Left
Center
1
Right
1
Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill
Novo Nordisk stock popped Tuesday on reports it's asked the FDA to approve its weight-loss pill, an oral version of Wegovy. The post Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill appeared first on Investor's Business Daily.
Coverage Details
Total News Sources3
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
